Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant
reforms aimed at reducing the financial burden of prescription drug costs
for Medicare Part D beneficiaries.
However, in addition to these reforms, the IRA redesigned the financial
structure of Part D by shifting a larger share of liability from the federal
government to plans and pharmaceutical manufacturers. As plans absorb
this increased... Read more
The MAPRx coalition has championed policies in Part D that improve the affordability of medications and beneficiary access to those medications, including provisions of the Inflation Reduction Act (IRA) that establish an out-of-pocket cap in Part D and the Medicare Prescription Payment Plan. MAPRx strongly opposes the GUARD Model and urges CMS to abandon this proposal and withdraw the model.... Read more
The Medicare prescription drug benefit (Medicare Part D) has been an enormous help to beneficiaries and a policy success story by providing coverage for prescription drugs. The program filled a major gap in Medicare’s benefits and has done so with consistently high satisfaction among beneficiaries. However, for the MPPP to have a greater impact and operate as intended by Congress... Read more
See the new infographic for changes to the 2026 Medicare Part D program
... Read moreMedicare Part D prescription drug plans will have an out-of-pocket maximum of $2,100 for 2026 and beneficiaries can also opt in to the Medicare Prescription Payment Plan (MPPP)—a new program that lets you pay for prescriptions in monthly installments. The MAPRx Coalition has created this patient guide with more information.
The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2025 – December 7, 2025 for coverage beginning January 1, 2026. Plans make changes to benefits and costs, and there are also many new changes for the 2026 plan year.
MAPRx encourages both new and existing beneficiaries to use this time period to... Read more
We are eager to hear about your experiences with the Medicare prescription drug program. We would like to hear about both good and bad experiences that you have had selecting and signing up for a plan, getting your drugs, and paying for your drugs. The form below will allow you to write your story.
Thank you for taking the time to tell us your story.